| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.00012 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.00015 | 1 |